{
    "Trade/Device Name(s)": [
        "ACCU-CHEK Compact Plus System",
        "ACCU-CHEK Compact Plus Test Strip",
        "ACCU-CHEK Compact Plus Meter",
        "ACCU-CHEK Compact Plus Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K113614",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031755"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "February 12, 2013",
    "Summary Letter Received Date": "February 6, 2013",
    "Submission Date": "February 5, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACCU-CHEK Compact Plus Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection",
        "Mut. Q-GDH enzymatic method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for ACCU-CHEK Compact Plus Blood Glucose Monitoring System for quantitative glucose measurement using Mut. Q-GDH enzymatic electrochemical detection",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips or palm by individuals with diabetes at home as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}